GDANSK, July 10 (Reuters) - Poland's Celon Pharma (CLNP.WA), opens new tab believes its experimental treatment for acute schizophrenia could eventually achieve annual sales in the billions of dollars, Chief Executive Maciej Wieczorek said on Wednesday.
KIELPIN, Poland, June 17, 2024 (GLOBE NEWSWIRE) -- Celon Pharma S.A. (CLN.WA) today announced the successful completion of a Phase 2 trial a JAK/ROCK dual inhibitor in the treatment of Rheumatoid...